A Phase 3, Randomized Study to Evaluate the Efficacy and Safety ofLenvatinib (E7080/MK-7902) plus Pembrolizumab (MK-3475) plusChemotherapy Compared with Standard of Care Therapy as First-lineIntervention in Participants with Advanced/Metastatic GastroesophagealAdenocarcinoma (LEAP-015)

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2020
This article has no abstract
Epistemonikos ID: 13ad9c8cea6a8099384a07594a691a702d166ce4
First added on: Apr 17, 2025